NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE (NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCH) — FDA Approval ANDA076518 (PERRIGO)
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE (NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCH) — FDA Approval ANDA076518 (PERRIGO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE; Active ingredients: NAPROXEN SODIUM; PSEUDOEPHEDRINE
| Brand name | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE |
|---|---|
| Active ingredients | NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Application number | ANDA076518 |
| Sponsor | PERRIGO |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Over-the-counter |
| Products in application | 1 |
| First approval date | 20040317 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →